| 2025 | 2024 | 2023 | 2022 | 2018 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 258,6 M € | +92.2% | 134,6 M € | +135.9% | 57,0 M € | +9.1% | 52,3 M € | -32.1% | 76,9 M € | +41.4% | 54,4 M € | +8.7% | 50,0 M € | +5.1% | 47,6 M € | +45.4% | 32,7 M € | -19.7% | 40,8 M € | -19.2% | 50,5 M € | -4.5% | 52,8 M € | +14.3% | 46,2 M € | +14.0% | 40,6 M € | +33.2% | 30,5 M € | |
| EBITDA | 35,5 M € | +1083.6% | 3,0 M € | -85.3% | 20,4 M € | +157.8% | -35,3 M € | -420.8% | 11,0 M € | +325.5% | 2,6 M € | +28.7% | 2,0 M € | -62.3% | 5,3 M € | +208.7% | -4,9 M € | -134.3% | -2,1 M € | -123.2% | 9,0 M € | -14.3% | 10,5 M € | +160.0% | 4,0 M € | +177.6% | 1,5 M € | +128.0% | -5,2 M € | |
| Operating profit | 14,9 M € | +325.4% | -6,6 M € | -180.9% | 8,2 M € | +118.0% | -45,5 M € | -995.5% | 5,1 M € | +208.1% | -4,7 M € | +20.9% | -5,9 M € | -870.5% | -612,4 k € | +94.0% | -10,2 M € | -49.2% | -6,8 M € | -241.7% | 4,8 M € | -21.4% | 6,1 M € | +2835.6% | 208,1 k € | +115.1% | -1,4 M € | +84.7% | -9,0 M € | |
| Profit/loss | 11,9 M € | +257.9% | -7,5 M € | -233.5% | 5,6 M € | +112.1% | -46,7 M € | -1338.6% | 3,8 M € | +167.0% | -5,6 M € | +23.5% | -7,4 M € | -411.3% | -1,4 M € | +86.2% | -10,4 M € | -38.3% | -7,5 M € | -257.6% | 4,8 M € | -11.9% | 5,4 M € | +291.9% | -2,8 M € | -162.8% | -1,1 M € | +92.1% | -13,6 M € | |
| Equity | 74,2 M € | +19.0% | 62,4 M € | -10.8% | 69,9 M € | +8.8% | 64,2 M € | +691.9% | 8,1 M € | +47.2% | 5,5 M € | -50.5% | 11,1 M € | -41.0% | 18,9 M € | -7.1% | 20,3 M € | -33.9% | 30,7 M € | -19.7% | 38,3 M € | +14.3% | 33,5 M € | +19.3% | 28,1 M € | -9.1% | 30,9 M € | +1310.7% | 2,2 M € | |
| Total assets | 153,5 M € | +11.0% | 138,2 M € | +19.8% | 115,3 M € | -16.9% | 138,8 M € | +51.6% | 91,6 M € | +25.2% | 73,2 M € | -6.6% | 78,3 M € | +11.0% | 70,6 M € | +10.0% | 64,1 M € | +0.6% | 63,8 M € | -3.6% | 66,1 M € | +6.4% | 62,1 M € | -6.0% | 66,1 M € | -6.7% | 70,9 M € | -0.5% | 71,2 M € | |
| Cash | 6,5 M € | -5.3% | 6,9 M € | +414.3% | 1,3 M € | -96.8% | 42,3 M € | +1336.5% | 2,9 M € | +41.3% | 2,1 M € | +62.6% | 1,3 M € | -23.7% | 1,7 M € | +10825.4% | 15,4 k € | -98.0% | 782,0 k € | +4313.0% | 17,7 k € | +3.1% | 17,2 k € | -96.5% | 489,7 k € | +1014.1% | 44,0 k € | -91.3% | 504,7 k € | |
| Debts | 65,4 M € | +25.4% | 52,2 M € | +147.7% | 21,1 M € | -66.1% | 62,1 M € | -14.5% | 72,7 M € | +20.6% | 60,3 M € | +10.1% | 54,7 M € | +32.5% | 41,3 M € | +16.0% | 35,6 M € | +30.1% | 27,4 M € | +13.1% | 24,2 M € | -1.1% | 24,5 M € | -24.4% | 32,4 M € | -8.8% | 35,5 M € | -47.2% | 67,3 M € | |
| Staff | 587,2 | 558,2 | 540,6 | 515,6 | 367,1 | 278,1 | 265,6 | 274 | 297,9 | 339,5 | 356,3 | 392,4 | 356,5 | 290,4 | 293,6 | |||||||||||||||
Public limited company · Bruxelles · incorporated on 22/04/1999 · 587,2 ETP
Public limited company profitable and well capitalised. Cash position declining (-5.3%).
Solid counterparty for a standard engagement.
Novo Nordisk Production Belgium SA is a Public limited company incorporated in 1999. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Bruxelles. It employs on average 587,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette